David Shaw’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-506,384
| Closed | -$7.97M | – | 4936 |
|
|
2024
Q1 | $7.97M | Buy |
506,384
+117,721
| +30% | +$1.81M | 0.01% | 1537 |
|
|
2023
Q4 | $6.27M | Buy |
388,663
+71,702
| +23% | +$915K | 0.01% | 1729 |
|
|
2023
Q3 | $4.03M | Sell |
316,961
-64,851
| -17% | -$895K | ﹤0.01% | 2001 |
|
|
2023
Q2 | $5.38M | Sell |
381,812
-408,974
| -52% | -$5.85M | 0.01% | 1813 |
|
|
2023
Q1 | $12.2M | Sell |
790,786
-207,707
| -21% | -$3.47M | 0.01% | 1217 |
|
|
2022
Q4 | $16.4M | Buy |
998,493
+208,082
| +26% | +$3.38M | 0.02% | 1057 |
|
|
2022
Q3 | $14.6M | Buy |
790,411
+623,526
| +374% | +$9.79M | 0.02% | 1067 |
|
|
2022
Q2 | $2.19M | Buy |
166,885
+102,991
| +161% | +$1.14M | ﹤0.01% | 2983 |
|
|
2022
Q1 | $592K | Sell |
63,894
-76,014
| -54% | -$646K | ﹤0.01% | 4267 |
|
|
2021
Q4 | $1.37M | Buy |
+139,908
| New | +$2.63M | ﹤0.01% | 3681 |
|
|
2021
Q1 | – | Sell |
-16,943
| Closed | -$789K | – | 4573 |
|
|
2020
Q4 | $967K | Buy |
16,943
+5,921
| +54% | +$351K | ﹤0.01% | 3043 |
|
|
2020
Q3 | $565K | Sell |
11,022
-10,003
| -48% | -$490K | ﹤0.01% | 3164 |
|
|
2020
Q2 | $1.26M | Buy |
+21,025
| New | +$1.12M | ﹤0.01% | 2770 |
|
|
2020
Q1 | – | Sell |
-3,351
| Closed | -$186K | – | 4343 |
|
|
2019
Q4 | $209K | Sell |
3,351
-34,338
| -91% | -$1.63M | ﹤0.01% | 3784 |
|
|
2019
Q3 | $1.28M | Buy |
+37,689
| New | +$1.12M | ﹤0.01% | 2682 |
|
|
2018
Q3 | – | Sell |
-9,231
| Closed | -$363K | – | 4041 |
|
|
2018
Q2 | $363K | Buy |
+9,231
| New | +$272K | ﹤0.01% | 3284 |
|
Other funds holding DCPH
David Shaw's DCPH Position: Q2 2024 in Review
David Shaw sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 506,384 shares — an estimated $7.97M sold.
David Shaw first reported a position in DCPH in Q2 2018 and held it in 16 quarters. The position peaked at $16.4M in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- David Shaw reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- David Shaw sold 506,384 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $7.97M.
- David Shaw first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 16 quarters.
- David Shaw's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $16.4M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.